The onset of spring signals the arrival of various seasonal allergies. Although there are existing treatments available for people suffering from hay fever or asthma attacks, HealthDay News reports that a new type of treatment already working the rounds in Europe and Asia may soon work its magic in America. The Food and Drug Administration (FDA) is currently testing the viability of treatments via pills or under-the-tongue drops; however, evaluators will still have to determine the appropriate potency of such drugs for the US market.
The potential of these oral treatments is immense, especially in places like Arizona whose arid climate and vulnerability to dust storms make its locals more prone to allergies. National Jewish Health allergy specialist Dr. Harold Nelson said this will appeal to patients who are leery about asthma shots, but cautioned them to wait for FDA approval before going to the nearest drugstore with a prescription in hand. Once approved, an Arizona allergy and asthma center such as the Adult and Pediatric Allergy Associates, P.C. can include oral medication in their treatment plans.
An Arizona allergy treatment practitioner usually tests the patient’s skin for signs of an allergy. The results of that test will help the practitioner devise a personal treatment plan for the individual. The patient is expected to follow the plan to the letter for maximum effectiveness.
Apart from receiving medication, asthma can be prevented in a number of ways. These include cleaning the surroundings free of dust and staying away from pets or smokers. Johns Hopkins otolaryngology associate professor Dr. Sandra Lin said children are often vulnerable to allergens from such environments, and that proper health measures along with oral treatments show promise in sparing them from allergy-induced asthma attacks.
The proposed anti-allergen pills or drops are designed to reduce the immune system’s sensitivity to allergen contamination. Patients will still have the option to take current asthma treatments administered through injections to the arm, or through the use of breath inhalers or nebulizers. However, the FDA has long since phased out several over-the-counter inhalers – specifically those that use epinephrine – due to concerns over greenhouse gases used in pumping the substances out of the vial, leaving certain inhalers available only by prescription.
Specialists in the treatment of Arizona allergies, such as those from the Adult and Pediatric Allergy Associates, P.C., are dedicated to easing the woes of allergic and asthmatic patients. The practice can offer a new range of options for their patients once the FDA comes through with approval for oral treatments.